The Market For DNA-Sequncing-Based Down’s Syndrome Tests Could Exceed $6 Billion Posted on 28/02/2014 by forbes On Wednesday night the New England Journal of Medicine published a study showing that a new, DNA-sequencing based blood test provides a dramatic improvement in accuracy at screening for Down’s...